TD Cowen lifts target for Myriad Genetics stock to USD 4.50
Published on 10/15/2026 at 21:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst targets and valuation
- TD Cowen set a USD 4.50 target on October 13, 2026.
- MarketBeat reported an eight-analyst average target of USD 3.93 on October 13, 2026.
- Myriad Genetics stock costs EUR 3.90 at Lang & Schwarz on October 15, 2026 at 9:01 p.m. CEST.
- The stock's 52-week range is USD 2.74 to USD 8.59.
TD Cowen raised its Myriad Genetics target from USD 4.00 to USD 4.50 on October 13, 2026, while maintaining a Hold rating, according to Markets Insider. The new target is 2.51 percent above the USD 4.39 Nasdaq price dated October 15, 2026 at 3:05 p.m. ET. Myriad Genetics stock was trading at EUR 3.90 at Lang & Schwarz on October 15, 2026 at 9:01 p.m. CEST.
Analyst views remain divided
The broader target picture is less optimistic. MarketBeat reported on October 13, 2026 that eight analysts held a consensus Reduce rating and an average 12-month target of USD 3.93. That average stood 10.48 percent below the USD 4.39 Nasdaq price, putting the latest TD Cowen target above the wider group view.
Price position within the range
Myriad Genetics traded between a 52-week low of USD 2.74 and a 52-week high of USD 8.59 in the quoted market data. The USD 4.39 Nasdaq price therefore sat 48.89 percent below the yearly high and 60.22 percent above the yearly low on October 15, 2026. The company operates in healthcare and medical diagnostics and research, with molecular tests spanning oncology, women's health and pharmacogenomics.
Valuation and business scale
Myriad Genetics had a market capitalization of USD 419.9 million on October 15, 2026. The quoted trailing price-to-earnings ratio was negative 3.67, reflecting the company's loss position, while no dividend yield was reported. The next scheduled earnings date was not included in the cited investor-relations calendar, so the analyst target remains the clearest dated valuation marker for this report.
Price and market context
The USD 4.39 Nasdaq quote was 5.78 percent above the previous session's USD 4.15 level at 3:05 p.m. ET on October 15, 2026. The euro quotation from Lang & Schwarz was captured later in the Berlin trading window, when the Xetra session had already ended.
Market context: Market report S&P 500.
